ABSTRACT
INTRODUCTION
Wheezing in infancy is common, however only a small proportion of these children will continue to wheeze into later childhood and beyond. A number of studies have attempted to classify wheezing pre-school children into different phenotypes in order to assist investigation of the pathways of asthma development. The Tucson Children's Respiratory Study (TCRS) published the first classification according to wheezing status up to 6 years of age 1 . TCRS characterised children into 4 groups, namely never wheezed, transient early wheeze, late wheeze and persistent wheeze; persistent and late-onset wheeze were associated with atopy, however transient early wheeze was not, as confirmed by further studies using this classification [2] [3] [4] [5] . TCRS found persisting lung function deficits in those with transient wheeze, suggesting this was a phenomenon of small airways, with resolution of wheeze once airway calibre improves with growth, albeit without returning to normal 1 . Whilst TCRS found that persistent wheezers did not have lung function deficits at birth, the Copenhagen Prospective Studies on Asthma and Childhood (COPSAC) cohort of at-risk children did find diminished lung function shortly after birth in those with asthma at 7 years 6 and the authors hypothesized that perhaps TCRS had been underpowered to find this statistical difference. Likewise, Turner et al found lung function deficits that preceded the development of asthma 7 . A cohort from Perth, Australia performed longitudinal lung function testing, comparing VmaxFRC at birth and FEF25-75 at 4-6 years and 11 years. They found that transient wheezers (wheeze at 0-3 years) had the best lung function of all groups at birth, but this diminished over time with reference to other groups, supporting the idea that transient wheeze is associated with ongoing lung function deficits beyond the symptomatic period. Development of late and persistent wheeze has been associated with reduced airway function interacting with atopic sensitisation, immune dysregulation and airway remodelling, in line with the classical view of asthma pathogenesis [8] [9] [10] [11] . It is possible that persistent wheezers represent an overlap between these theories of transient wheeze and more typical asthma pathogenesis with later resolution of wheeze by puberty in those who are not atopic It is this latter group that may be at increased risk of chronic obstructive pulmonary disease (COPD) in later life owing to continued poor lung function 14 15 . A recent application of latent class growth analysis, which differs slightly from LLCA, in the Columbia Children's Centre for Environmental Health (CCEH) cohort of African-American and Latino children identified 4 classes that were similar to those in the TCRS study 16 . Spycher et al also used LLCA in 1650 UK children, identifying 3 phenotypes of wheeze and 2 phenotypes of cough 17 .
We hypothesised that the statistically derived ALSPAC 6-class model could be validated using longitudinal lung function and atopic sensitisation data from the first 6 years of life.
METHODS
Participants were mother-child pairs from the Southampton Women's Survey; a cohort study with the objective, among others, of studying early life environmental influences on child growth and development, including respiratory disease and asthma in childhood 18 . 
Atopy
Atopy was defined as any allergen response ≥ 3 mm against cat, dog, house dust mite (Dermatophagoides pteronyssinus), grass pollens, egg and milk allergens (Hollister-Stier, Spokane, WA) at ages 1 (n=1494) and 3 years (n=1255). At 6 year follow-up (n=699), tree pollen was added (ALK Abelló Hørsholm, Denmark). Readings were considered valid only in the presence of appropriate positive and negative control responses.
Airway inflammation
Exhaled nitric oxide (FeNO) was measured with a NIOX ® chemiluminescence analyser (Aerocrine, Sweden) at a controlled expiration of 50ml/sec, by trained research nurses. The technique used was in line with the ERS/ATS recommendations 20 and a mean value was calculated from three readings where possible. FeNO data were normalised using an inverse square root transformation then standardised as a z-score. The sign of the values was reversed so that high untransformed FeNO values gave rise to high standardised scores.
Allocation to wheeze phenotype groups
The ISAAC core questionnaire wheezing module was delivered by research nurses 21 . Mothers were asked at each visit whether their child had experienced 'episodes of chestiness associated with wheezing or whistling in his/her chest in the last 12 months'. Using wheeze data collected in the first year, at 2/3 years, and at 6 years old, the children were grouped into both the Tucson [1] ; never, transient early, late, persistent groups, and ALSPAC based phenotypes 13 ; never, early, transient, intermediate-onset, late-onset, and persistent wheeze. Our 'early' and 'transient' groups were so named in order to differentiate them from the Tucson 'transient early' group and be roughly equivalent to the ALSPAC 'transient early' and 'prolonged transient' groups 12 . Table 1 shows how the children were classified into the wheezing phenotypes using the questionnaire data from 6m, 12m, 2 years, 3 years and 6 years, and how our naming of groups corresponds to the ALSPAC phenotypes. Children who wheezed in the first year and at 6 years but not in between were classified as persistent wheezers, in line with the ALSPAC/PIAMA LLCA allocations 13 , however we acknowledge that these could be children who are a combination of the early and late-onset groups.
Lung function
In Infancy: As previously described 19 infant lung function measurements were obtained during quiet sleep augmented by oral chloral hydrate (75-100mg/kg). V'maxFRC was measured using rapid thoracic compression (RTC) during tidal breathing using an inflatable jacket and a leak-free facemask with Fleisch pneumatachograph (Dynasciences, Blue Bell, CA). RTC from a raised volume manoeuvre was used to calculate FEV0.4. Data were collected in RASP software (Physiologic Ltd, Newbury, Berks, UK), with SQUEEZE software (Paul Dixon, London, UK) used to analyse the flow-volume curves and calculate FEV0.4. V'maxFRC and FEV0.4 were corrected for age at test but not for size 19 .
At age 6 years: Spirometry was performed according to ATS/ERS guidelines 20 but without noseclips.
Experienced research nurses used a portable Koko spirometer and incentive software (KoKo version 4; PDS Instrumentation; Louisville, USA) to record flow-volume loops. FEV1, FEV1/FVC and FEF25-75 were corrected for height and gender, and expressed as percent predicted 22 .
Bronchial hyper-responsiveness (BHR) testing was performed according to ATS/ERS guidelines 20 using dosimeter administered methacholine (Koko; PDS Instrumentation; Louisville, USA) via an air-driven nebuliser (Sidestream®; Respironics, UK). Methacholine doses ranged from 0.06 mg/ml to 16 mg/ml with termination at either the upper concentration or a 20% fall in FEV1. Data were transformed using the formula Log.slope=100/[regression slope of FEV1 drop and log10(cumulative methacholine dose) + 10] in order to remove negative values and produce a normal distribution of the variable, with a lower value indicating greater responsiveness.
Statistical Analysis
Using STATA/SE 11.0, Poisson regression with robust variance was performed for atopic sensitisation outcomes 23 giving the relative risk of atopy for each wheeze group at 1,3 and 6 years of age compared to those who never wheezed.. Linear regression was used for lung function outcomes, within which the following were assessed for potential confounding and included in the analysis if significantly correlated with the outcome and exposure; maternal asthma, smoking in pregnancy, smoke exposure in 1 st year and 6 th year of life, gestation, birth weight, birth weight z score (adjusted for gestation), sex, parity, maternal atopy, pets in the home, breastfeeding duration, social class, maternal education and month of birth. This is in line with recent published recommendations for confounders in studies of childhood asthma 24 . The prevalence of the potential confounders for each of the ALSPAC and TCRS groups can be found in supplementary table 5 and 6. Infant lung function, BHR and FeNO required log transformation to normalise and therefore they are presented as ratios of geometric means, which provides consistency with the presentation of the ALSPAC data 13 .
RESULTS

Study population
A total of 1840 (92.6%) children were seen at 1 year, 1735 (87.3%) at 2 years, 1640 (82.5%) at 3 years and 940 (47.3%) at 6 year follow up (Figure 1 ). Children were more likely to have complete follow-up to 6 years if they were higher social class, had more highly educated parents, or were exposed to lower rates of smoking, as shown in supplementary table 1. There were no important differences in participants with spirometry in the 6-year follow-up versus those without and those with infant lung function versus those without (supplementary tables 2 and 3). The differences between those with follow-up and those without were included in our analysis as potential confounders (tables E4, E5 and E6). 
Lung function in infancy and childhood
Lower infant lung function (V'maxFRC) was seen in ALSPAC and TCRS transient groups (p<0.05) and in the ALSPAC persistent (p<0.05) but not the TCRS persistent wheeze groups ( No associations were seen between BHR and any of the wheeze phenotypes. Infant and 6 year lung function parameters were converted to z scores to enable tracking over time (figures 3a and 3b).
When compared to others in our cohort, persistent wheezers' z scores for our lung function parameters remain below all other groups. Although the transient wheeze group are below the other groups (except persistent) in infancy, there is some improvement by age 6 relative to other wheezing groups. They do, however remain below intermediate and late-onset groups despite the fact these two groups are now symptomatic and transient wheezers are not.
Atopy in infancy and childhood
None of the groups that had ceased wheezing by 6 years of age showed an increased risk of atopy at 1, 3 or 6 years of age (table 4, figure 3 ). Intermediate-onset wheezers showed an increased risk for atopy at all ages with relative risks of 3.3, 3.0 and 2.9 at 1, 3 and 6 years (all p<0.001), however lateonset and persistent wheezers did not show an increased risk of atopy until 3 years of age (late -RR 2.5 at 3 and 6 years, p<0.05, persistent -RR 2.4 and 2.0 at 3 and 6 years respectively, p<0.05).
These RR are shown across the three ages in figure 3c . TCRS groups show a different pattern ( 12 , and our data have been able to show that wheeze at 6 years is not only associated with skin sensitisation but also with FeNO which is an indirect estimate of lower airway eosinophilic inflammation. We have also shown that those who wheeze only in the first year of life appear distinct from other 'transient' wheezing groups, in that they show no lung function deficits in infancy or childhood and are perhaps similar to children in the never/infrequent wheeze group.
In keeping with previous studies 1 6 we found that, when compared to children who have never wheezed, children with transient wheeze outside the first year are more likely to have persistently lower lung function even when symptoms have resolved. In contrast to the ALSPAC/PIAMA 13 and TCRS studies 1 , the intermediate onset and late onset groups did not show significantly diminished lung function at 6 years compared to those who never wheeze. It may be that greater numbers in these previous studies gave the power to detect small differences.
It is widely accepted that transient early wheeze may be related to small airways 1 , with improvement in wheeze as the child grows; however the pathogenesis is clearly more complex than this. By separating the TCRS 'transient early' wheeze into ALSPAC 'early' (wheeze only in the first year)
and 'transient' wheeze, differing associations were seen. Early wheeze was not associated with diminished lung function or atopy, whilst the remainder of the transient wheezers showed diminished infant lung function (V'maxFRC) with persistence of these deficits up to 6 years (FEF25-75 and FEV1), at which time they were, by definition, asymptomatic. This is in keeping with the theory that transient wheeze is a product of reduced airway calibre that improves with age, such that children are no longer symptomatic but still have minor deficits in lung function. Since persistent wheeze was not significantly associated with atopy at 1 year, this group may reflect a larger group of those with diminished lung function at birth that either cease to wheeze with growth (transient wheeze), have such diminished airway function that they fail to grow out of wheeze by 6 years (persistent nonatopic wheeze) or develop atopic sensitisation that leads to persistent wheezing at 6 years (classical asthma). It is possible that the 'early' wheezers have normal airways but an altered immune response to early viral infections that manifests as wheeze in the first year of life but improves as the immune system matures. Since there was no significant difference in month of birth between the early group and the never wheezers or transient wheezers (data not shown), this does not simply reflect a seasonal effect of increased respiratory tract infections. ALSPAC had classified children into a never/infrequent group 12 and our 'early' phenotype may correspond more closely to this group, differentiating them from those who wheeze as a result of poor lung function and possibly reflecting a difference between bronchiolitis and viral-induced wheeze. It is possible that the PIAMA LLCA analysis, which found a 5-class model to be optimal, had included these children within the never/infrequent group 13 and that our infant lung function data allowed identification of this extra class. The existence of this early group suggests that many of those who wheeze only in the first year of life do not do so as a result of significantly altered lung function. This is in contrast to the theory suggested by Young et al who found that those who wheezed only in the first year of life had impaired lung function that resolved by 12m of age, whereas wheezing through the first 2 years or in year 2 only was associated with persisting lung function deficits 11 Our findings differ from ALSPAC/PIAMA as they found that all wheeze groups had significantly lower FEV1 at 8 years, whereas our intermediate and late groups did not show any significant difference from those who never wheezed. This is most likely a reflection of the greater power in their studies and may also be why we did not show lung function deficits in the intermediate/late
groups prior to the onset of wheeze, as previously suggested by the Aberdeen cohort 7 and COPSAC 6 . Like the Perth cohort 26 , we found significantly reduced lung function in persistent wheezers both shortly after birth and at 6 years, but, unlike them, we found transient wheezers had diminished lung function shortly after birth as well. We had the benefit of greater numbers in this wheeze group and, in line with the original TCRS infant lung function findings, our results likely reflect a significant difference in lung function at birth in transient wheezers. Our findings that wheeze at school age was related to atopic sensitisation reinforces the findings of the German Multicentre Allergy Study (MAS), a birth cohort of 1314 healthy children, who found that persistence of wheezing through school years was related to development of atopy 4 .
Strengths of this study are its infant lung function data, exhaled nitric oxide measurements and longitudinal atopic sensitisation data. In particular, other cohorts have not included 1 year allergic sensitisation data. Together, these data allow tracking of lung function and onset of atopy in relation to different wheeze phenotypes. A particular limitation of our study is the small numbers of children who had infant lung function and were wheezing at 6 years of age. This lack of power may explain the absence of association between wheeze phenotypes and FEV0.4 in infancy (figure 3). Similarly, there was a surprising lack of significant association with bronchial hyper-responsiveness at 6 years in children who were wheezing at 6 years. Again, lack of power is likely to be an issue as there were few children with BHR data in the intermediate (n=17), late (n=4) and persistent groups (n=17). A planned meta-analysis of cohort data may overcome this problem. As with most cohort studies of this type, there was a tendency for children of higher social class to attend follow-up; however we controlled for associated confounders (maternal smoking in pregnancy and during childhood, education and social class) in our analysis. There were also differences between SWS and ALSPAC in wheezing time points used to classify the phenotypes with ALSPAC having data from 6m, 12m, 18m 30m, 42m, 54m, 69m and 81m. Rather than map our follow-up time points to these, we used the phenotype tracking figure that arose from their analysis and fitted our data to this graph 12 . Also, the 6 year lung function outcomes showed lung function that was statistically significantly lower in transient and persistent wheezers, however when expressed as percent predicted they are still within the expected normal range. This means that the differences are potentially important on a population level but may not be clinically significant in the individuals.
Many studies have attempted to identify risk factors for asthma/wheeze including fetal/postnatal growth parameters 27 28 , genetics [29] [30] [31] [32] [33] and infant lung function 7 26 34 , with varying results. It is only by understanding the wheeze phenotypes that these relationships can be better elucidated and the diluting effects of grouping wheeze together in a small number of categories can be overcome. show infant lung function deficits in the persistent group and lack of diminished FEV1 at 6 years in the transient wheezers. There is now good evidence that COPD and all-cause mortality in later life is related to airway function in childhood 14 15 35 36 and this may be related to wheeze phenotype 37 . Since infant lung function is impractical in most wheezing children, it is wheeze phenotype, particularly our transient wheeze group, that may provide information about later risk of asthma/COPD and risk of mortality from a wide range of causes.
In conclusion, using longitudinal lung function and atopic sensitisation data, the SWS cohort has not only validated the statistically derived ALSPAC phenotypes of childhood wheeze, but has also provided insights to the underlying pathophysiology. Our findings confirm the existence of an 'intermediate-onset' phenotype that is similar to late-onset wheeze but has earlier atopic sensitisation. The SWS cohort demonstrates the utility of separating the 'transient early' wheeze group, by considering those who wheeze in their first year only as a separate group.. We suggest that future research should focus on a 6-class model of early childhood wheeze. Further work is needed to investigate whether the group of children who only wheeze in the first year of life reflect a separate phenotype or can be considered alongside those who never wheeze and thus a 5-class model may be appropriate class model of early childhood wheeze. 
